chronic pain, ecology, immunology
Infographic: A Painful Pathway
Infographic: A Painful Pathway
Catherine Offord | Dec 31, 2017
Since the mid-2000s, the voltage-gated sodium channel NaV1.7 has emerged as a promising target for a new class of analgesics.
Infographic: Two Pain Paths Diverge in the Body
Infographic: Two Pain Paths Diverge in the Body
Mark R. Hutchinson | Dec 31, 2017
The acute pain that results from injury or disease is very different from chronic pain.
Antiviral Immunotherapy Comes of Age
Antiviral Immunotherapy Comes of Age
Lucas Laursen | Dec 4, 2017
T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections. 
Immune System Targets Diverse Viruses Using the Same Small Peptide
Immune System Targets Diverse Viruses Using the Same Small Peptide
Catherine Offord | Dec 1, 2017
A single receptor on natural killer cells recognizes an amino acid sequence conserved across Zika, dengue, and related pathogens.
European Research Council Founder, Molecular Biologist Dies
European Research Council Founder, Molecular Biologist Dies
Catherine Offord | Nov 20, 2017
Fotis Kafatos, a Greek researcher famous for his work on malaria, has died at age 77.
Optogenetic Therapies Move Closer to Clinical Use
Optogenetic Therapies Move Closer to Clinical Use
Shawna Williams | Nov 16, 2017
With a clinical trial underway to restore vision optogenetically, researchers also see promise in using the technique to treat deafness, pain, and other conditions.
Researchers Build a Cancer Immunotherapy Without Immune Cells
Researchers Build a Cancer Immunotherapy Without Immune Cells
Abby Olena | Nov 13, 2017
A team has engineered two stem cell lines into “synthetic T cells” that destroy breast cancer cells in vitro. 
Tracking Invasive Fire Ants in Asia
Tracking Invasive Fire Ants in Asia
Steve Graff | Nov 1, 2017
These insect transplants have the potential to wreak economic havoc by outcompeting native insects and destroying crops.
FDA Approves Second CAR T-Cell Therapy
FDA Approves Second CAR T-Cell Therapy
Ashley P. Taylor | Oct 19, 2017
The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas. 
Germany Sees Drastic Decrease in Insects
Germany Sees Drastic Decrease in Insects
Anna Azvolinsky | Oct 18, 2017
A 27-year-long study finds insect biomass has declined by about 75 percent.